- Replimune Group Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Replimune Group Inc RP1 Program Update Call TranscriptDec 05, 2023
- Replimune Group Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Replimune Group Inc to Host Virtual Investor Event TranscriptDec 07, 2022
- Replimune Group Inc To Host Investor Day TranscriptMar 30, 2022
- Replimune Group Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Replimune Group Inc Annual Shareholders Meeting TranscriptSep 08, 2021
- Replimune Group Inc Virtual Investor Event Corporate Call TranscriptJun 03, 2021
- Replimune Group Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Replimune Group Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Replimune Group Inc to Provide Phase 1/2 Clinical Data Update on Patients with Melanoma and Non-Melanoma Skin Cancers - Conference Call TranscriptJun 03, 2020
- Replimune Group Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
Replimune Group Inc to Host Virtual Investor Event Transcript
Good morning, and thank you for joining our investor conference call. We're excited to have this opportunity to share with everyone our first data set from a study being run with the registrational intent.
Before we begin, I need to highlight our forward-looking statement. On Slide 3, I'm Philip Astley-Sparke, CEO of Replimune. And I have with me today from management Robert Coffin, our President and Chief R&D Officer; and Sushil Patel, our Chief Commercial Officer.
We're also very pleased to have with us today several leading physicians from sites, all with considerable experience of using our products. Dr. Mark Middleton, PI on the IGNYTE study, for which we are reporting data today. Mark is Professor of Experimental Cancer Medicine and Consultant Medical Oncologist at the Oxford Cancer Centre and Head of the Department of Oncology at the University of Oxford.
Dr. Mike Wong, Professor in the Department of Melanoma Medical Oncology at MD Anderson. And Dr. Kevin Harrington, Professor in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)